Effect of corticosteroid in improving the results of embryo transfer in patients with endometriosis
Phase 3
- Conditions
- Endometriosis and infertility.
- Registration Number
- IRCT20231015059725N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 110
Inclusion Criteria
Age between 20 and 40 years
Having endometriosis based on laparoscopic evidence
Exclusion Criteria
presence of severe sperm disorders in the patient's wife based on WHO 2021 criteria
congenital or acquired uterine anomalies in the patient
Suffering from thrombophilic diseases such as hemophilia
Suffering from autoimmune diseases such as lupus
The use of hormonal treatments by the individual
Taking immunosuppressant drugs by the individual
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chemical pregnancy. Timepoint: Pregnancy check with beta hCG test two weeks after embryo transfer. Method of measurement: Beta hCG test.;Abortion. Timepoint: Continued pregnancy up to 20 weeks. Method of measurement: Examining the view of a live fetus with ultrasound.;Live birth. Timepoint: Pregnancy with a gestational age of more than 28 weeks. Method of measurement: Examining the live fetus with ultrasound.;Clinical pregnancy. Timepoint: Sonography 6 weeks later beta hCG positive. Method of measurement: Visualization of fetal heart rate by ultrasound.;Ongoing pregnancy. Timepoint: Continued pregnancy up to 12 weeks. Method of measurement: Ultrasound visualization of a live fetus at 12 weeks.
- Secondary Outcome Measures
Name Time Method